- Hong
Kong Banks | NEUTRAL
- Exide
Industries (EXID IN) | HOLD
- Indofood
Sukses (INDF IJ) | HOLD
- Indofood
CBP (ICBP IJ) | HOLD
- Ramayana
Lestari (RALS IJ) | BUY
- Malaysia
Banking Sector
- Bank
of the Philippine Islands (BPI PM) | HOLD
- DBS
Group (DBS SP) | BUY
- United
Overseas Bank (UOB SP) | BUY
- OCBC
Bank (OCBC SP)
- Yangzijiang
Shipbuilding (YZJSGD SP)
- SMRT
(MRT SP) | SELL
- Cosco
Corp (COS SP) | SELL
- Siam
Cement (SCC TB)
- Bangkok
Dusit Medical Services (BGH TB) | HOLD
|
Hong Kong Banks
|
Mar14 data: Decline in total
loans
|
Sector Update
|
- Decline
in HKD and USD deposits; ongoing rise in RMB deposits
- Annualized
loan growth has reduced to 23% in 1Q14
- Slight
rise in HKD funding costs. Maintain NEUTRAL.
|
Exide Industries (EXID IN)
|
4Q signals recovery; we increase
TP
|
Share Price: INR127 | Target
Price: INR121(-5%) | MCap (USD): 1.8B | ADTV (USD): 3.7M
|
- Maintain
HOLD but raise TP by 16% to INR121. 4Q EPS was the best in the
past three quarters owing to strong seasonal improvement in
the industrial battery segment.
- Historically,
EXID�s PER ranged 15-17x one-year
forward earnings. YTD EXID�s
stock price has risen 24% and is now trading at PER of 17x
FY15F excluding value of investments.
- We
will upgrade to BUY if catalysts emerge ie. rise in battery
demand following general elections. Key risk: weak monsoon
from anticipated El Nino effect driving down rural demand.
|
Indofood Sukses (INDF IJ)
|
Margins up but expect pressure
|
Share Price: IDR7,025 | Target
Price: IDR8,000(+14%) | MCap (USD): 5.3B | ADTV (USD): 6M
|
- Maintain
HOLD with TP of IDR8,000, which implies a 17.9x FY14F PER.
- 1Q14
net profit was above our estimates owing to one-off forex
gain. All segments performed well, except the flat consumer
branded EBIT growth.
|
Indofood CBP (ICBP IJ)
|
Margins Compression
|
Share Price: IDR10,000 | Target
Price: IDR11,000(+10%) | MCap (USD): 5.0B | ADTV (USD): 4M
|
- Maintain
HOLD with TP of IDR11,000, which implies a 24.5x FY15F PER.
- 1Q14
results in-line with our estimates. All segments, except
noodles and NSF, suffer margin pressure.
|
Ramayana Lestari (RALS IJ)
|
1Q14 profit fell, expect
improvement
|
Share Price: IDR1,235 | Target
Price: IDR1,800(+46%) | MCap (USD): 759M | ADTV (USD): 0.3M
|
- 1Q14
earnings fell slightly (-3% YoY), mainly due to the decline in
margin and FX loss. Expect improvement in the coming quarters,
and thus reiterate BUY and IDR1,800 TP.
- Revenue
grew a decent 9% YoY on SSSG of 7.5% as per Mar14 YTD. EBIT
margin declined slightly to 2.1% vs. 1Q13�s 2.3%.
- In
1Q14, its supermarket business recorded higher revenue growth
than department store due to the impact from natural disasters
in several areas.
|
Malaysia Banking Sector
|
Not in vogue just yet
|
Sector Update
|
- Subdued
interest in Malaysian banks at this stage due to premium
valuations and the country�s
austerity drive.
- NEUTRAL
on the sector, top banking picks continue to be AMMB, HL Bank
and HLFG.
- Consider
MPHB Capital as a mid-cap deeply discounted financial services
play � BUY with an RNAV TP of
MYR2.42.
|
Bank of the Philippine Islands
(BPI PM)
|
1Q14 results disappoint
|
Share Price: PHP90.65 | Target
Price: PHP93.50(+3%) | MCap (USD): 8.0B | ADTV (USD): 5M
|
- Maintain
HOLD and TP of PHP93.50, equivalent to 2014F PBV of 2.5x.
- 1Q14
earnings came in lower than expected at PHP3.6b, down 57% YoY.
- Loan
growth of 25% boosted net interest income by 15% but treasury
operations likely weakened.
|
DBS Group (DBS SP)
|
A blowout quarter
|
Share Price: SGD16.53 | Target
Price: SGD19.60 (+19%) | MCap (USD): 31.9B | ADTV (USD): 40M
|
- 1Q
results beat expectations by a mile, lifted by strong NIM,
customer-related non-interest income and lower provisions.
- Key
positives: Strong NIM rebound, strong fee income, strong
credit quality, ample liquidity (73% SGD LDR).
- Reiterate
BUY. Remains our preferred pick. DBS is well-positioned to
benefit from a rising interest rate environment.
|
United Overseas Bank (UOB SP)
|
A decent quarter
|
Share Price: SGD21.18 | Target
Price: SGD23.60(+11%) | MCap (USD): 12.2B | ADTV (USD): 41M
|
- 1Q14 results
surpassed expectations on lower taxes.
- Directionally,
certain operating trends were weaker than that of DBS and
OCBC, characterised by weaker NIM (-1bp QoQ) and weaker fee
income (-4.8% QoQ, -8.6% YoY).
- Maintain
BUY with a SGD23.60 TP, based on 13x FY14E P/E.
|
OCBC Bank (OCBC SP)
|
1Q14: A strong start to the year
|
Share Price: SGD9.47 | Target
Price: SGD9.08(-4%) | MCap (USD): 26.0B | ADTV (USD): 30M
|
- Like
DBS, OCBC�s NIM also surprised on the
upside on larger loan spreads and better gapping
opportunities.
- Other
notable trends: Strong loan traction, solid credit quality,
ample liquidity (78.8% SGD LDR).
- Purchase
of WHB remains a concern. Maintain HOLD with TP of SGD9.08,
based on 1.24x FY14E P/BV.
|
Yangzijiang Shipbuilding (YZJSGD
SP)
|
Earnings beat, upgrade to HOLD
|
Share Price: SGD1.10 | Target
Price: SGD1.18(+7%) | MCap (USD): 3.4B | ADTV (USD): 8M
|
- 1Q14
results beat expectations on higher contributions from HTM
investments.
- Shipbuilding
margin decline inevitable but bottom-line profitability to be
held up by non-core businesses.
- Upgrade
to HOLD with higher SOTP-based TP of SGD1.18.
|
SMRT (MRT SP)
|
Smaller bus loss gives cheer
|
Share Price: SGD1.22 | Target
Price: SGD0.65(-47%) | MCap (USD): 1.5B | ADTV (USD): 2M
|
- Bus
operations posted sharp drop in loss but fare-based business
still in the red. Fare hike implemented in April will ensure
continued improvement in profitability.
- Earnings
raised by 17-29% to reflect lower cost estimates.
- Maintain
SELL with higher TP of SGD0.65.
|
Cosco Corp (COS SP)
|
Execution remains key drag
|
Share Price: SGD0.72 | Target
Price: SGD0.65(-10%) | MCap (USD): 1.3B | ADTV (USD): 0.6M
|
- 1Q14
PATMI of SGD12.6m (+29.6% YoY, +174.1% QoQ) missed
expectations after adjusting for irregular items.
- Weak
execution remains key drag on profitability.
- Maintain
SELL and TP of SGD0.65, pegged to trough P/BV level of 1.1x.
|
Siam Cement (SCC TB)
|
1Q14 disappointing � BUY on dips
|
Share Price: THB442.00 | Target
Price: THB550(24.5%) | MCap (USD): 16.4B | ADTV (USD): 18M
|
- 1Q14
net THB8.4bn, down 5% YoY. Adjusted for FX elements, bottom
line was 12% below our forecast - very disappointing.
- Where
SCC disappointed us was in �other
income�, 56% below our forecast � not much dividends this
time. Revenue grew 11% YoY, 1% below our forecast, but 26% of
our FY14F. GM rose to 16.5% vs 15.2% in 1Q13 (we expected
16.8%).
- Overall,
maintain BUY. We remain positive on the long-term outlook for
SCC and recommend buying the stock on dips as the
disappointing results likely to weigh on the shares.
|
Bangkok Dusit Medical Services
(BGH TB)
|
Flat quarter
|
Share Price: THB1.43 | Target
Price: THB14.00(+879%) | MCap (USD): 69M | ADTV (USD): 1M
|
- Maintain
HOLD with TP of THB14, based on DCF at 9.5% WACC and 3%
terminal growth. Our TP implies 2014 multiples are 4.8x PBV
and 30.1x PER.
- Expect
1Q14F net profit of THB1,932m, and this would 28% of our FY
forecast. Earnings growth is driven by volume growth and
improved margin from cost control measures.
- Utilisation
rate in 1Q14 is expected to hit 75% (66% in 4Q13, 73% in
1Q13), volume growth 7% YoY and price to rise 3% YoY. Hospital
revenue is forecast to increase 4% QoQ and 10% YoY; International
patients� revenue could jump 4% YoY.
|
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.